Wela Strategies’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $679K | Buy |
6,128
+303
| +5% | +$33.6K | 0.27% | 30 |
|
|
2025
Q1 | $653K | Sell |
5,825
-850
| -13% | -$95.2K | 0.28% | 26 |
|
|
2024
Q4 | $617K | Buy |
6,675
+816
| +14% | +$75.4K | 0.27% | 28 |
|
|
2024
Q3 | $491K | Buy |
5,859
+187
| +3% | +$15.7K | 0.21% | 30 |
|
|
2024
Q2 | $389K | Buy |
5,672
+266
| +5% | +$18.2K | 0.18% | 43 |
|
|
2024
Q1 | $396K | Buy |
5,406
+525
| +11% | +$38.5K | 0.19% | 42 |
|
|
2023
Q4 | $395K | Buy |
4,881
+229
| +5% | +$18.6K | 0.21% | 37 |
|
|
2023
Q3 | $349K | Buy |
4,652
+61
| +1% | +$4.57K | 0.21% | 38 |
|
|
2023
Q2 | $354K | Buy |
4,591
+19
| +0.4% | +$1.46K | 0.27% | 32 |
|
|
2023
Q1 | $379K | Sell |
4,572
-844
| -16% | -$70K | 0.2% | 35 |
|
|
2022
Q4 | $465K | Buy |
5,416
+319
| +6% | +$27.4K | 0.26% | 28 |
|
|
2022
Q3 | $314K | Buy |
5,097
+377
| +8% | +$23.2K | 0.21% | 32 |
|
|
2022
Q2 | $292K | Buy |
4,720
+140
| +3% | +$8.66K | 0.17% | 33 |
|
|
2022
Q1 | $272K | Buy |
4,580
+271
| +6% | +$16.1K | 0.14% | 40 |
|
|
2021
Q4 | $313K | Buy |
4,309
+132
| +3% | +$9.59K | 0.15% | 34 |
|
|
2021
Q3 | $292K | Sell |
4,177
-46
| -1% | -$3.22K | 0.15% | 33 |
|
|
2021
Q2 | $291K | Buy |
4,223
+140
| +3% | +$9.65K | 0.12% | 36 |
|
|
2021
Q1 | $264K | Buy |
+4,083
| New | +$264K | 0.14% | 38 |
|
|
2020
Q4 | – | Sell |
-3,252
| Closed | -$205K | – | 42 |
|
|
2020
Q3 | $205K | Buy |
+3,252
| New | +$205K | 0.13% | 40 |
|